Latest

• Practical guidelines for antibiotic prescribing in breast surgery: antibiotic prophylaxis and treatment of surgical site infections and implant-associated infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(3):244-273

• Piperacillin-tazobactam in the treatment of severe intra-abdominal and urinary tract infections in the Russian Federation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(2):171-187

• Rhino-cerebral mucormycosis in patients with COVID-19: clinical cases and treatment in a regional hospital

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(1):113-120

• Ceftaroline fosamil – fifth-generation cephalosporin with anti-MRSA activity in the treatment of severe infections in pediatric practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(1):40-58

• Cefpodoxime proxetil – new opportunities in antibacterial therapy of respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):366-371

• Oral third-generation cephalosporin cefpodoxime in the therapy of respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):266-276

• Microbiologic diagnosis of community-acquired urinary tract infections: official statements of the board of experts

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):221-224

• The known-unknown: third- and fourth-generation cephalosporins combined with sulbactam

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):41-55

• Probiotics: controversial issues

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(4):345-360

• Psychobiotics: a new way in psychopharmacology, or How do bacteria manage our brain?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(2):108-133

• Ceftazidimeavibactam use in children and adolescents

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):173-183

• Pneumococcal vaccination in adult patients with comorbidities: a review of the clinical practice guidelines

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(4):254-265

• Biomarkers of infection in the optimization of antibacterial therapy: justified expectations

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(3):175-187

• Gastrointestinal adverse drug reactions and antibiotic-associated diarrhea during antibiotic therapy in outpatient practice: prevention and treatment

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):196-206

• The evidence base and practical approaches to probiotic use in clinical practice: a focus on Lactobacillus rhamnosus GG and Bifidobacterium lactis Вb-12

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):100-118

• New probiotic strain Streptococcus salivarius K12 in clinical practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):92-99

• Current approaches to prophylaxis and treatment of travelers’ diarrhea

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):172-180

• Ceftazidime-avibactam: new rules for the game against multidrug-resistant gram-negative bacteria

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):24-34

• Antibiotic dosing in obesity: size does matter?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):214-228

• Efficacy and Safety of Lactobacillus acidophilus LA-5 and Bifidobacterium lactis BB-12 Combination in Gastroenterology, Pediatrics and Allergology

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(2):113-124

• Treatment of Acute Tonsillitis/Pharyngitis: Current Guidelines and Russian Local Situation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(3):198-211

• Review of Current Guidelines on the Management of Pediatric Patients with Acute Bacterial Rhinosinusitis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(3):176-190

• In There Any Significant Difference in the Efficacy of 16-, 15-, and 14-Member Macrolides

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):165-166

• What is the Appropriate Time for Administering Probiotics?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):279-282

• Safety and Efficacy of Antibiotics Used in Outpatient Setting

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):67-84

• Approaches to Diagnosis and Treatment of Acute Male Urethritis: Results of Multicenter Observational Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):19-39

• Selection of Macrolide Resistance

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):255-259

• Strain-specific Effects of Probiotics

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):253-254

• Clinical Perspectives of Tigecycline

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):127-145

• Common Questions About the Treatment of Community-Acquired Pneumonia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):82-85

• Emerging Concepts in Use of Macrolides in Pregnancy and Lactation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):41-53

• From 2004 to 2009: Whether Pharmacists’ Recommendations on Acute Urethritis Have Changed over 5 Years?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(3):253-263

• Potential for Use of Spiramycin in Clinical Practice

  Клиническая Микробиология и Антимикробная Химиотерапия. 2009; 11(3):218-238

• Respiratory Tract Infections: New View on the Old Problem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(2):143-151

• Meropenem in the Treatment of Severe Infections in Children

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):322-332

• Doripenem: a New Carbapenem Antimicrobial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(3):245-259

• Pneumonia in Nursing Homes: Current View on Problem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):4-19

• Potential for the Use of Probiotics in Clinical Medicine

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(2):151-172

• Severe Acute Respiratory Syndrome (SARS)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(3):225-242